Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

Some Stage III Colon Cancer Patients May Need Only Half of the Standard Chemotherapy Course

Cancer

Cancer Research

Oncology

2017

English

The Clinical Implications of Immunogenomics in Colorectal Cancer: A Path for Precision Medicine

English

Displaced Children With Cancer in Lebanon: A Sustained Response to an Unprecedented Crisis

English

Population-Based Data Registries Suggest Novel Insight Into Malignancy and Metabolism

English

A Phase 2 Trial of Abiraterone Acetate Without Glucocorticoids for Men With Metastatic Castration-Resistant Prostate Cancer

English

Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2-Sn-38 Antibody-Drug Conjugate for the Treatment of Diverse Epithelial Cancers: Safety and Pharmacokinetics

English

Reply to When Flawed Modeling Justifies Cost-Effectiveness: Making Sense of “Band-Aid” Modeling

English

Smokeless Tobacco Product May Increase Mortality Rate in Patients With Prostate Cancer

English

Determinants of the Recommended Phase 2 Dose of Molecular Targeted Agents

English

Dose Determination for Molecularly Targeted Therapies: Much Ado About Nothing

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

Some Stage III Colon Cancer Patients May Need Only Half of the Standard Chemotherapy Course

The Clinical Implications of Immunogenomics in Colorectal Cancer: A Path for Precision Medicine

Displaced Children With Cancer in Lebanon: A Sustained Response to an Unprecedented Crisis

Population-Based Data Registries Suggest Novel Insight Into Malignancy and Metabolism

A Phase 2 Trial of Abiraterone Acetate Without Glucocorticoids for Men With Metastatic Castration-Resistant Prostate Cancer

Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2-Sn-38 Antibody-Drug Conjugate for the Treatment of Diverse Epithelial Cancers: Safety and Pharmacokinetics

Reply to When Flawed Modeling Justifies Cost-Effectiveness: Making Sense of “Band-Aid” Modeling

Smokeless Tobacco Product May Increase Mortality Rate in Patients With Prostate Cancer

Determinants of the Recommended Phase 2 Dose of Molecular Targeted Agents

Dose Determination for Molecularly Targeted Therapies: Much Ado About Nothing